Home > Insider Trading > Filing (0001455244-10-000100)

Filing Details

Accession Number:: 0001455244-10-000100
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-26 13:00:00
Reporting Period:: 2010-04-22

Filing Date:: 2010-04-26
Accepted Time:: 2010-04-26 17:23:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
919722	Supergen Inc	SUPG	Pharmaceutical Preparations (2834)	911841574

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1360509	Florian Schonharting	Oestergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No
1360573	Christian Hansen	Oestergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No
1451330	K/S Equity Public Nb	Oestergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.001	Disposition	2010-04-22	2,600	$3.38	6,402,616	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-22	200	$3.39	6,402,416	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	5,052	$3.06	6,397,364	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	100	$3.07	6,397,264	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	17,815	$3.07	6,379,449	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	20,661	$3.08	6,358,788	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	5,000	$3.09	6,353,788	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	5,328	$3.10	6,348,460	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	3,459	$3.11	6,345,001	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	2,268	$3.12	6,342,733	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	100	$3.13	6,342,633	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	67,074	$3.13	6,275,559	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	1,800	$3.14	6,273,759	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	1,600	$3.14	6,272,159	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	200	$3.14	6,271,959	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	47,642	$3.14	6,224,317	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	26,507	$3.15	6,197,810	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	1,400	$3.16	6,196,410	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	34,752	$3.16	6,161,658	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	800	$3.17	6,160,858	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	10,100	$3.17	6,150,758	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	11,145	$3.18	6,139,613	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	100	$3.19	6,139,513	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	1,693	$3.19	6,137,820	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	500	$3.20	6,137,320	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	200	$3.21	6,137,120	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	900	$3.21	6,136,220	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2010-04-23	203	$3.22	6,136,017	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners.
Christian Hansen and Florian Sch?nharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Sch?nharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein.